**Calimmune, Instant BioScan and Medical Referral Source were all Desert Angels deals and fall into the “string of tech startup buyouts”**
This week’s $91 million acquisition of Tucson biotech drug startup Calimmune Inc. by a global drug company is fresh evidence of the Old Pueblo’s ability to nurture promising tech companies.
The deal by Australia-based CSL Ltd. for Calimmune is the biggest and latest in a string of buyouts of Tucson-based tech startups in the last few years.
In addition to a $91 million upfront payment, CSL could end up paying up to $325 million in performance payments over several years for Calimmune.
Read full article here